AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,897,000 | -38.4% | 555,186 | 0.0% | 0.18% | -43.4% |
| Q3 2021 | $6,329,000 | -28.8% | 555,186 | 0.0% | 0.33% | -17.0% |
| Q2 2021 | $8,889,000 | -36.9% | 555,186 | -29.6% | 0.39% | -32.3% |
| Q1 2021 | $14,089,000 | +29.1% | 788,410 | -2.4% | 0.58% | +24.4% |
| Q4 2020 | $10,911,000 | +14.8% | 807,656 | 0.0% | 0.47% | -0.8% |
| Q3 2020 | $9,506,000 | -20.3% | 807,656 | 0.0% | 0.47% | -38.7% |
| Q2 2020 | $11,921,000 | +17.6% | 807,656 | +7.5% | 0.77% | +13.7% |
| Q1 2020 | $10,138,000 | -37.4% | 750,974 | +12.1% | 0.68% | -35.1% |
| Q4 2019 | $16,195,000 | +25.8% | 670,036 | 0.0% | 1.04% | -52.7% |
| Q3 2019 | $12,878,000 | -23.6% | 670,036 | +17.5% | 2.21% | -6.5% |
| Q2 2019 | $16,845,000 | -21.3% | 570,036 | +26.5% | 2.36% | -25.5% |
| Q1 2019 | $21,409,000 | +31.6% | 450,714 | 0.0% | 3.17% | +38.2% |
| Q4 2018 | $16,271,000 | -35.3% | 450,714 | +10.3% | 2.29% | +14.8% |
| Q3 2018 | $25,147,000 | +194.5% | 408,562 | +223.2% | 2.00% | +132.6% |
| Q2 2018 | $8,538,000 | +383.7% | 126,397 | +26.4% | 0.86% | +575.6% |
| Q2 2015 | $1,765,000 | -86.6% | 100,000 | -76.2% | 0.13% | -88.7% |
| Q1 2015 | $13,152,000 | +7.4% | 419,652 | 0.0% | 1.12% | +12.9% |
| Q4 2014 | $12,250,000 | – | 419,652 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |